Echinacea Reduces Antibiotics by Preventing Respiratory Infections: A Meta-Analysis (ERA-PRIMA)

Area of Science:

• Herbal medicine
• Infectious disease prevention
• Pharmacology

Background:

• Respiratory tract infections (RTIs) are a primary driver of antibiotic prescriptions.
• Secondary bacterial infections pose a significant risk in RTIs.
• Preventing RTIs could reduce antibiotic use and combat antimicrobial resistance.

Purpose of the Study:

• To evaluate Echinacea's efficacy in preventing RTIs and their complications.
• To assess the safety profile of Echinacea for RTI prevention.
• To determine if Echinacea can decrease the need for antibiotic therapy.

Main Methods:

• A systematic review and meta-analysis of 30 clinical trials involving 5652 subjects.
• Searched databases: EMBASE, PubMed, Google Scholar, Cochrane DARE, clinicaltrials.gov.
• Analyzed data on RTI occurrence, complications, antibiotic use, and adverse events.

Main Results:

• Echinacea significantly reduced monthly RTI occurrence (RR=0.68) and the number of patients with RTIs (RR=0.75).
• Reduced risk of recurrent infections (RR=0.60), RTI complications (RR=0.44), and antibiotic therapy need (RR=0.60).
• Alcoholic Echinacea purpurea extracts showed the strongest effect, reducing antibiotic days by 80% (IRR=0.21).
• Adverse event rates were similar between Echinacea and control groups.

Conclusions:

• Echinacea safely and effectively prevents RTIs and associated complications.
• Echinacea use can decrease the demand for antibiotic treatments.
• Variations in Echinacea preparations influence their effectiveness.